JP2022545226A5 - - Google Patents
Info
- Publication number
- JP2022545226A5 JP2022545226A5 JP2022510971A JP2022510971A JP2022545226A5 JP 2022545226 A5 JP2022545226 A5 JP 2022545226A5 JP 2022510971 A JP2022510971 A JP 2022510971A JP 2022510971 A JP2022510971 A JP 2022510971A JP 2022545226 A5 JP2022545226 A5 JP 2022545226A5
- Authority
- JP
- Japan
- Prior art keywords
- receptor
- item
- neuron
- pharmaceutical composition
- composition
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Granted
Links
Priority Applications (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| JP2024180241A JP2025004243A (ja) | 2019-08-21 | 2024-10-15 | 神経学的疾患のための組成物および方法 |
Applications Claiming Priority (3)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US201962889963P | 2019-08-21 | 2019-08-21 | |
| US62/889,963 | 2019-08-21 | ||
| PCT/US2020/047503 WO2021035179A1 (en) | 2019-08-21 | 2020-08-21 | Compositions and methods for neurological diseases |
Related Child Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2024180241A Division JP2025004243A (ja) | 2019-08-21 | 2024-10-15 | 神経学的疾患のための組成物および方法 |
Publications (3)
| Publication Number | Publication Date |
|---|---|
| JP2022545226A JP2022545226A (ja) | 2022-10-26 |
| JP2022545226A5 true JP2022545226A5 (cg-RX-API-DMAC7.html) | 2023-08-29 |
| JP7781052B2 JP7781052B2 (ja) | 2025-12-05 |
Family
ID=72356519
Family Applications (2)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2022510971A Active JP7781052B2 (ja) | 2019-08-21 | 2020-08-21 | 神経学的疾患のための組成物および方法 |
| JP2024180241A Pending JP2025004243A (ja) | 2019-08-21 | 2024-10-15 | 神経学的疾患のための組成物および方法 |
Family Applications After (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2024180241A Pending JP2025004243A (ja) | 2019-08-21 | 2024-10-15 | 神経学的疾患のための組成物および方法 |
Country Status (7)
| Country | Link |
|---|---|
| US (1) | US20220348635A1 (cg-RX-API-DMAC7.html) |
| EP (1) | EP4017874A1 (cg-RX-API-DMAC7.html) |
| JP (2) | JP7781052B2 (cg-RX-API-DMAC7.html) |
| CN (1) | CN114746450A (cg-RX-API-DMAC7.html) |
| AU (2) | AU2020334147A1 (cg-RX-API-DMAC7.html) |
| CA (1) | CA3151920A1 (cg-RX-API-DMAC7.html) |
| WO (1) | WO2021035179A1 (cg-RX-API-DMAC7.html) |
Families Citing this family (9)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| IL311984A (en) | 2016-07-07 | 2024-06-01 | Hughes Howard Med Inst | Modified ligand-gated ion channels and methods of use |
| CN111556751B (zh) | 2017-11-10 | 2024-07-12 | 霍华休斯医学研究院 | 经修饰的配体门控的离子通道及使用方法 |
| AU2021329529A1 (en) * | 2020-08-21 | 2023-04-27 | Trames Bio, Inc. | Compositions and methods for neurological diseases |
| US20250009906A1 (en) * | 2021-11-19 | 2025-01-09 | President And Fellows Of Harvard College | Nociceptor-specific gene regulatory elements for the treatment of pain |
| US20250145687A1 (en) * | 2022-01-31 | 2025-05-08 | Howard Hughes Medical Institute | Modified ligand-gated ion channels and methods of use |
| IL315059A (en) * | 2022-02-18 | 2024-10-01 | Trames Bio Inc | Ion channels that open using ligands and methods of using them |
| EP4514831A4 (en) * | 2022-04-27 | 2026-06-17 | Hughes Howard Med Inst | Chemogenetic receptors and their manufacturing and use processes |
| EP4702043A1 (en) * | 2023-04-28 | 2026-03-04 | Kriya Therapeutics, Inc. | Chimeric modified ion channels and uses thereof for treatment of trigeminal nerve disorders |
| WO2025117698A1 (en) * | 2023-12-01 | 2025-06-05 | Massachusetts Institute Of Technology | Ribozyme-enhanced rna trans-splicing |
Family Cites Families (20)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| EP0733103B1 (en) | 1993-11-09 | 2004-03-03 | Targeted Genetics Corporation | Generation of high titers of recombinant aav vectors |
| FR2756297B1 (fr) | 1996-11-22 | 1999-01-08 | Centre Nat Rech Scient | Procede de production de virus recombinants |
| WO1999006562A1 (en) | 1997-07-31 | 1999-02-11 | Chiron Corporation | Method enabling readministration of aav vector via immunosuppression of host |
| US6566118B1 (en) | 1997-09-05 | 2003-05-20 | Targeted Genetics Corporation | Methods for generating high titer helper-free preparations of released recombinant AAV vectors |
| US6995006B2 (en) | 1997-09-05 | 2006-02-07 | Targeted Genetics Corporation | Methods for generating high titer helper-free preparations of released recombinant AAV vectors |
| CA2995542A1 (en) | 1997-09-05 | 1999-03-11 | Genzyme Corporation | Methods for generating high titer helper-free preparations of recombinant aav vectors |
| EP1135468B1 (en) | 1998-11-10 | 2010-01-06 | University Of North Carolina At Chapel Hill | Virus vectors and methods of making and administering the same |
| US6498244B1 (en) | 1999-05-28 | 2002-12-24 | Cell Genesys, Inc. | Adeno-associated virus capsid immunologic determinants |
| WO2001023001A2 (en) | 1999-09-29 | 2001-04-05 | The Trustees Of The University Of Pennsylvania | Rapid peg-modification |
| AU2003267174A1 (en) | 2002-05-09 | 2003-11-11 | Memory Pharmaceuticals Corporation | Qm-7 and qt-6 cells transfected with mutant cell surface expressed channel receptors and assays using the transfected cells |
| TW200412942A (en) | 2002-08-06 | 2004-08-01 | Abbott Lab | Appetite control method |
| WO2004074245A2 (en) | 2003-02-14 | 2004-09-02 | Memory Pharmaceuticals Corporation | Monkey alpha-7 nicotinic acetylcholine receptor and methods of use thereof |
| US9441244B2 (en) | 2003-06-30 | 2016-09-13 | The Regents Of The University Of California | Mutant adeno-associated virus virions and methods of use thereof |
| US20060166363A1 (en) | 2004-01-27 | 2006-07-27 | Sergei Zolotukhin | Modified baculovirus expression system for production of pseudotyped rAAV vector |
| WO2009042723A1 (en) | 2007-09-25 | 2009-04-02 | California Institute Of Technology | Transgenic mice expressing hypersensitive nicotinic receptors |
| JP5511144B2 (ja) | 2008-02-12 | 2014-06-04 | 学校法人福岡大学 | てんかんモデル非ヒト哺乳動物 |
| WO2010042799A2 (en) | 2008-10-09 | 2010-04-15 | Howard Hughes Medical Institute | Novel chimeric ligand-gated ion channels and methods of use thereof |
| US11713470B2 (en) * | 2017-03-20 | 2023-08-01 | University of Pittsburgh—of the Commonwealth System of Higher Education | Targeted gene therapies for pain and other neuro-related disorders |
| CN111556751B (zh) * | 2017-11-10 | 2024-07-12 | 霍华休斯医学研究院 | 经修饰的配体门控的离子通道及使用方法 |
| IL274702B2 (en) * | 2017-11-27 | 2026-04-01 | Coda Biotherapeutics Inc | Compounds and methods for neurological diseases |
-
2020
- 2020-08-21 JP JP2022510971A patent/JP7781052B2/ja active Active
- 2020-08-21 AU AU2020334147A patent/AU2020334147A1/en not_active Abandoned
- 2020-08-21 WO PCT/US2020/047503 patent/WO2021035179A1/en not_active Ceased
- 2020-08-21 CN CN202080067794.7A patent/CN114746450A/zh active Pending
- 2020-08-21 EP EP20767671.9A patent/EP4017874A1/en active Pending
- 2020-08-21 CA CA3151920A patent/CA3151920A1/en active Pending
- 2020-08-21 US US17/636,235 patent/US20220348635A1/en not_active Abandoned
-
2024
- 2024-10-15 JP JP2024180241A patent/JP2025004243A/ja active Pending
-
2026
- 2026-07-06 AU AU2026205301A patent/AU2026205301A1/en active Pending
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| JP7482549B2 (ja) | 新規のマイクロジストロフィンおよび使用の関連する方法 | |
| US12263231B2 (en) | Adeno-associated virus virions for treatment of epilepsy | |
| JP2021503960A5 (cg-RX-API-DMAC7.html) | ||
| JP2022141670A5 (cg-RX-API-DMAC7.html) | ||
| RU2019103488A (ru) | Способы и композиции для лечения нарушений и заболеваний, связанных с rdh12 | |
| JP7289306B2 (ja) | 網膜障害を治療するための組成物及び方法 | |
| IL278213B1 (en) | A gene therapy vector encoding an e3 ubiquitin protein ligase (park2) and use thereof in treating or inhibiting the onset of parkinson’s disease (pd) | |
| JP2022531809A (ja) | ATPase媒介性疾患の処置のための組成物および方法 | |
| JP2023534037A5 (cg-RX-API-DMAC7.html) | ||
| RU2018112506A (ru) | Лечение пигментного ретинита | |
| JP2024513949A5 (cg-RX-API-DMAC7.html) | ||
| JP2023538130A5 (cg-RX-API-DMAC7.html) | ||
| JP2023514446A5 (cg-RX-API-DMAC7.html) | ||
| JP2021075550A (ja) | グルカゴン類似ペプチド−1受容体亢進剤を含む筋減少症治療用薬学組成物 | |
| JP2022513454A (ja) | AIMP2-DX2およびmiR-142の標的核酸を含むベクター、ならびにその使用 | |
| JP2022512579A5 (cg-RX-API-DMAC7.html) | ||
| JP2025508429A5 (cg-RX-API-DMAC7.html) | ||
| JP2021534206A5 (cg-RX-API-DMAC7.html) | ||
| JP2024133479A5 (cg-RX-API-DMAC7.html) | ||
| EP4008789B1 (en) | Bicistronic aav vector for rna interference in als | |
| JP2022519596A (ja) | Cln3ポリヌクレオチドのアデノ随伴ウイルス送達 | |
| JP2023543361A (ja) | Neurod1及びdlx2ベクター | |
| CN115475247B (zh) | β2-微球蛋白或其抑制剂的制药用途 | |
| WO2023231778A1 (zh) | 用于治疗粘多糖贮积症iiia型的转基因表达盒 | |
| JP2024505197A5 (cg-RX-API-DMAC7.html) |